Previous Article | Next Article 
Molecular and Cellular Biology, May 2001, p. 3589-3597, Vol. 21, No. 10
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.10.3589-3597.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Protein Interactions of the MLL PHD Fingers
Modulate MLL Target Gene Regulation in Human Cells
Keri
Fair,1
Melanie
Anderson,1
Elena
Bulanova,1
Huaifeng
Mi,2
Maximilian
Tropschug,2 and
Manuel
O.
Diaz1,*
Cancer Center, Medical Center, Loyola
University
Chicago, Maywood, Illinois 60153,1
and Institut für Biochemie und Molekularbiologie der
Universität Freiburg, D-79104 Freiburg, Germany2
Received 29 June 2000/Returned for modification 29 August
2000/Accepted 15 February 2001
 |
ABSTRACT |
The PHD fingers of the human MLL and Drosophila trx
proteins have strong amino acid sequence conservation but their
function is unknown. We have determined that these fingers mediate
homodimerization and binding of MLL to Cyp33, a nuclear cyclophilin.
These two proteins interact in vitro and in vivo in mammalian cells and colocalize at specific nuclear subdomains. Overexpression of the Cyp33
protein in leukemia cells results in altered expression of
HOX genes that are targets for regulation by MLL. These
alterations are suppressed by cyclosporine and are not observed in cell
lines that express a mutant MLL protein without PHD fingers.
These results suggest that binding of Cyp33 to MLL modulates its
effects on the expression of target genes.
 |
INTRODUCTION |
The myeloid lymphoid leukemia
(MLL) gene (also known as HRX, HTRX, and
ALL1) is involved in recurring chromosome translocations and
duplications associated with human leukemia (33, 40). The
MLL 430-kDa protein has two domains with extensive similarity to the
trithorax (trx) Drosophila protein (4, 8, 13,
34). trx is involved in the process of maintenance of gene
activity, an epigenetic mechanism that mediates the clonal inheritance
of cell fates during development (17). The trx
gene is the prototype of a group of genes (the trithorax group, or
trx-G) which regulate the activity of Drosophila type I
Hox genes and have related mutant homeotic phenotypes.
Another group of genes, the polycomb group, or Pc-G, that mediates gene
repression antagonizes the activating function of trx on its target
genes. Pc-G and trx-G proteins are components of chromatin and modify
gene activity by influencing chromatin structure at enhancers and
promoters (17). A similar interaction between Pc-G and
trx-G genes also regulates type I HOX gene expression in
mammals (14). Disruption of the maintenance mechanism by
mutation of MLL may contribute to the leukemogenic process.
One of the two main domains of similarity between MLL and trx is formed
by four Zn fingers of a special type called PHD (for plant homeodomain)
Zn fingers (4) and an atypical bromodomain (16) nested between the third and fourth fingers. PHD
fingers occur in a large number of proteins, most of which seem to be components of chromatin and/or regulators of gene activity
(1), but the PHD finger cluster of trx and MLL proteins
has special features conserved throughout evolution that suggest it is
a functional cassette.
The PHD finger cassette of MLL is conserved not only with the
Drosophila trx proteins but also with the mouse and puffer
fish MLL proteins and with the putative product of the human
MLL2 gene, a recently described close relative of
MLL (11) (Fig.
1). Each one of the four PHD fingers
within these proteins has distinctive characteristics. The third and
fourth PHD fingers have an N-terminal extension (not shown in Fig. 1)
including pairs of cysteines (CXXC) and/or histidine-cysteine pairs
(HXXC) that may form an additional Zn finger or may form a more complex
structure with the associated PHD finger. For that reason we call these
two fingers extended PHD fingers (ePHD fingers).

View larger version (41K):
[in this window]
[in a new window]
|
FIG. 1.
Alignment of the amino acid sequences of the second and
third PHD fingers of trx and MLL proteins. The N-terminal extension of
the third PHD finger is not shown. Conserved acidic (or amphotropic)
residues in the third PHD finger are underlined. Asterisks above the
alignments mark the positions of conserved pairs of C and H residues
that define the PHD fingers and, presumably, coordinate
Zn++ ions.
|
|
Because of their strong evolutionary conservation, it is suspected that
the PHD fingers play an important role in trx and MLL function.
Missense mutations within one of the PHD fingers of trx have a mutant
phenotype in Drosophila. Nevertheless, the function of the
PHD fingers is unknown. The PHD fingers have similarity in structure to
the RING finger, another motif frequently found in chromatin component
proteins. Since the RING fingers are involved in protein-protein
interactions, it has been proposed that the PHD fingers may have a
similar general function (1). In order to search for such
interactions we used the yeast two-hybrid system, finding that some of
the MLL and trx PHD fingers homodimerize. In addition, the MLL third
ePHD finger binds strongly to Cyp33, a nuclear cyclophilin with an
amino terminal RNA binding domain of the RRM type (3). We
have investigated the effects of Cyp33 on the gene regulatory functions
of MLL and have found that overexpression of Cyp33 does modulate the
transcriptional control of the human HOX genes by MLL.
 |
MATERIALS AND METHODS |
Yeast two-hybrid system.
The numbering of MLL amino acid
residues is according to the HRX amino acid sequence published by
Tkachuk et al. (34) (GenBank accession no. M31617). To
generate constructs for the yeast two-hybrid system, the MLL sequences
encoding PHD fingers 1, 2, and e3 (PHD1-3; amino acids [aa] 1394 to
1630) were cloned into the Gal4 DNA binding domain vector pGBT9
(Clontech). This construct is called pGBT9-PHD1-3. The same insert
(MLL; aa 1394 to 1630) was cloned into the Gal4 activation domain
vector pGAD424 (Clontech). The trx constructs pSN16 and pSN17 are
described in Breen and Harte (4) and contain an insert
encoding the trx PHD finger region (nucleotides 4508 to 6673; GenBank
accession no. M31617). For the yeast two-hybrid library screen, the
plasmid pGBT9-PHD1-3 and a cDNA library made from human HeLa cells in
the Gal4 activation domain vector pGAD GH (Clontech) were cotransformed
into the yeast strain Y190 (Trp
Leu
His
LacZ
). Approximately 10 million clones
were screened on Trp/Leu/His dropout media containing 35 mM
3-aminotriazole. Plasmid DNA was isolated from 60 His+
LacZ+ yeast clones and was used to transform competent
Escherichia coli strain KC8 (Trp
Leu
His
). Transformants were plated on
leucine-deficient M9 media to isolate the library plasmid from positive
clones. Plasmid DNA was extracted, was characterized, and then was
retransformed back into yeast strain Y190 with pGBT9-PHD1-3 or the
parental DNA binding domain vector pGBT9 alone. The 20 plasmids that
passed through these tests were sequenced, and their sequences were
compared to nucleotide and protein databases using the BLAST program.
Specific two-hybrid assays for protein interactions were performed for yeast strain Y190. As controls for nonspecific yeast two-hybrid protein
interactions, GBT-NonO and GAD-NonO plasmids were used (37). Tests for
-galactosidase activity were performed
by filter lift assay by using X-Gal as a substrate or were quantitated
from liquid culture using chlorophenol red
-D-galactopyranoside as a substrate.
Generation of deletion constructs.
Yeast two-hybrid
constructs were generated encoding each one of the MLL PHD fingers 1 to
4 separately or encoding different domains of Cyp33. PCR primers were
designed with ends that could be digested with BamHI to
amplify each cDNA segment. The PCR products were digested with
BamHI and cloned into pGAD424.
GST in vitro binding assays.
pGEX-KT-MLL clones contain
either MLL cDNA aa 1392 to 1700 (GST-MLL PHD1-3) or aa 1392 to 2000 fused to a glutathione S-transferase (GST) open reading
frame (ORF) (GST-MLL PHD1-4) (39). DNA encoding the Cyp33
ORF from pGAD GH Cyp33 was subcloned into the pGEX-4T-1 (Pharmacia)
PspA1 and XhoI restriction sites. The GST fusion
proteins were expressed in E. coli and purified according to
Grieco et al. (12). Expression plasmids encoding the
full-length MLL zinc finger region, aa 1392 to 2000, in pBluescript
S/K+ (Stratagene) or the full-length CYP33 cDNA in pSP6
(Promega) were used as templates for coupled in vitro
transcription/translation in a rabbit reticulocyte lysate system
(Promega) containing [35S]methionine (Amersham).
Radiolabeled protein was added directly to GST Sepharose beads loaded
with equal amounts of fusion proteins or GST alone in a binding buffer
(50 mM K phosphate, 150 mM KCl, 1 mM MgCl2, 5% glycerol,
0.01% Triton X-100). After 1 h of incubation at 4°C, the beads were
washed five times in the binding buffer and finally were boiled for 5 min in loading buffer. The supernatant was loaded on a sodium dodecyl
sulfate-15% polyacrylamide gel electrophoresis (SDS-15% PAGE) gel
and was fractionated.
Mammalian two-hybrid system.
The cDNAs encoding MLL zinc
fingers 1 to 3 or the entire Cyp33-encoding ORF were subcloned into the
multiple cloning site of the mammalian expression vector pVP-HA1 or
pVP-FLAG (35). The MLL zinc finger 1 to 3 cDNA was also
subcloned into the mammalian expression vector pCMV-Gal4
(35). Human 293 cells, NIH 3T3 cells, or COS cells were
cotransfected with the VP16 transactivation construct (6 µg), the
Gal4 DNA binding domain construct (6 µg), a Gal4 responsive
luciferase reporter gene (G5LUC) (4 µg), and a constitutively active
Renilla reporter gene (ptkRL) (1 µg). Transfections were
done using Superfect transfection reagent (Qiagen), and lysates were
analyzed using the Dual-Luciferase Reporter assay system (Promega) and
a luminometer (Turner Designs; 20/20).
Coimmunoprecipitation and Western analysis.
The GAL4-MLL
expression plasmid was constructed as described above for the mammalian
two-hybrid assay. FLAG-MLL and FLAG-Cyp33 were generated by excising
the MLL PHD1-3 cDNA or the CYP33 cDNA, respectively, from
the pVP-FLAG vector together with sequences that encode the FLAG
epitope. The inserts were then cloned into the NotI and
HindIII sites of pCMV-Not (35). Human 293 kidney cells were transiently transfected with 10 µg of each
expression construct using SuperFect transfection reagent (Qiagen).
After 48 h, cell lysates were prepared using a low-salt NP-40
buffer (10 mM HEPES buffer [pH 7.6], 250 mM NaCl, 0.1% Nonidet P-40, 5 mM EDTA). Polyclonal GAL4 antibody (Santa Cruz Biotech, Santa Cruz,
Calif.) or polyclonal antiserum to Cyp33 (22) was added to
the appropriate cell lysates with protein A agarose (Sigma) and was
rocked at 4°C. Protein A agarose was then pelleted and washed four
times with low-salt NP-40 buffer, was resuspended in Laemmli loading
buffer, and was boiled for 5 min. Supernatants were fractionated on an
SDS-15% PAGE gel and were transferred to an Immobilon-P membrane
(Millipore) for Western blot analysis with the FLAG-specific M5
monoclonal antibody (Sigma).
Immunofluorescence and confocal microscopy.
The
pFLAG-PHD-NTS-MLL was constructed in a multistep subcloning process.
The MLL cDNA fragment containing aa 15 to 708, which include the AT
hooks and all the elements involved in localization of MLL to nuclear
speckles (38, 39), was subcloned into plasmid pSP6
containing FLAG epitope sequences (pSP6-FLAG-NTS). The MLL PHD1-3
sequences were PCR amplified from cDNA and were cloned into the
EcoRI site of pSP6-FLAG-NTS. Then, the cDNA fragment containing PHD1-3, the nuclear targeting sequences (NTS), and the FLAG
epitope was excised from pSP6 and was subcloned into the
NotI and XbaI sites of pCMV-Not (Invitrogen). All
junctions and MLL-amplified sequences were verified by
dideoxy-nucleotide sequencing. The pHA-Cyp33 expression vector was
generated by subcloning the CYP33 cDNA along with the
influenza virus hemagglutinin (HA) epitope tag from pVP-HA-Cyp33 into
the NotI and HindIII sites of pCMV-Not. Human
HeLa cells were grown on coverslips overnight in six-well culture
dishes. The pFLAG-PHD-NTS-MLL and pHA Cyp33 plasmids were transiently
transfected together or each one separately into HeLa cells seeded on
coverslips. After 36 h the cells were washed with
phosphate-buffered saline (PBS) and fixed with 4% paraformaldehyde at
room temperature for 20 min and then with 100% methanol for 10 min at
20°C. After rehydration, cells were incubated for 2 h at room
temperature with mouse monoclonal M2 anti-FLAG antibody (Sigma) and rat
monoclonal anti-HA antibody (Boehringer Mannheim). Following three
washes, the cells were incubated with anti-mouse immunoglobulin G
(IgG)-Texas red (Jackson Immunoresearch) and anti-rat IgG-fluorescein
isothiocyanate (Boehringer Mannheim). Finally, the coverslips were
washed and mounted in DABCO antifade medium (Sigma). Stained cell
images were captured by using a Zeiss LSM510 confocal microscope with a
×60 objective and an optical slice set at 0.9 µm.
Overexpression of Cyp33 from a transfected expression
construct.
The construction of the plasmid pHA-Cyp33 was described
in the previous section. The deletion construct, pHA-RRM, which lacks the conserved cyclophilin domain, was generated using the restriction enzyme Bsu36I. Bsu36I cleaves 5' and 3' of the
cyclophilin domain of Cyp33. The deletion construct pHA-Cyp was
generated by amplifying the nucleotide sequence encoding the
cyclophilin domain of Cyp33 by PCR with specific primers (forward,
5'-CCATGGGCCCGCTCAATCCTCAGTG-3'; reverse,
5'-CTGCAGCACGTACTCCCCACAGTCGG-3'). The amplified DNA fragment was cloned into the vector pGMT (Promega), was cut with the
NcoI and PstI restriction enzymes, and was
inserted into the pVP-HA vector.
The suspension cell lines K562, ML-1, and THP1 (5 × 10
6 cells) were transiently transfected with 8 µg of DNA
from the above
constructs or from the pCMV-Not vector using Superfect
(Qiagen)
transfection reagent. Cells were harvested after 48 h,
and RNA
was isolated using Trizol (Gibco/BRL). Reverse transcriptase
PCR
(RT-PCR) was performed using Superscript II/RNase H reverse
transcriptase
(Gibco/BRL) using the following reverse primers; the cDNA
was
amplified by using the following specific primers for the different
genes, using HotStarTaq DNA polymerase (Qiagen):
HOXC8
forward
(5'-CCGCCAACACTAACAGTAGC-3');
HOXC8
reverse (5'-CAGTCCCAGGGCATGAGAG-3');
HOXC9
forward (5'-CCGGCAGCAAGCACAAAGA-3');
HOXC9
reverse (5'-CGCTCGGTGAGATTGAGAACC-3');
HOXC6
forward (5'-TAGTTCTGAGCAGGGCAGGACTGCG-3');
HOXC6
reverse
(5'-CCGCTCCGTAGCCGACCCCACTGT-3');
GAPDH
forward (5'-ACATCAAGAAGGTGAAGCAGG-3');
GAPDH
reverse (5'-TCTTCCTCTTGTGCTCTTGCTGG-3'); HA epitope forward
(5'-TACCCATATGACGTCCCAGAC-3'); RRM domain reverse
(5'-TGGTTTGGCCAAATTGACACG-3');
and cyclophilin domain
reverse (5'-CTGCAGCACGTACTCCCCACAGTCGG-3').
The effect of cyclosporine was tested in a similar experiment with the
following differences. At the time of transfection
and 24 h later,
cyclosporine dissolved in PBS-ethanol (50:50,
vol/vol) was added to the
cells to a final concentration of 1
µg/ml; an equivalent amount of
PBS-ethanol (50:50) was added to
the control cells. The cells were
harvested 48 h posttransfection,
and RNA was isolated using Trizol
(Gibco/BRL). RT-PCR was performed
using a Marathon cDNA kit
(Clontech).
 |
RESULTS |
Protein interactions of the MLL PHD finger domain.
To
determine whether the zinc finger region of MLL can mediate
dimerization, we tested a series of hybrid GAL4-MLL fusion polypeptides
for interaction in the yeast two-hybrid system. Pairs of the fusion
constructs were cotransformed into the yeast strain Y190, and positive
protein interactions were determined by growth on media lacking
histidine and by positive
-galactosidase activity. A summary of the
yeast two-hybrid results is presented in Table 1 and Fig.
2. Positive protein interactions
occurred between pairs of hybrid constructs containing the first three
complete PHD zinc fingers (PHD1-3) in both bait and prey vectors
(Table 1; Fig. 2A). Positive interactions occurred as well between the first three complete zinc fingers in the bait vector and only the
second PHD finger in the prey vector (PHD2) but not with the first
(PHD1) or third (PHD3) PHD zinc fingers (Fig. 2A; Table 1). These
results indicate that the PHD1-3 polypeptides can homodimerize and
that the second PHD finger is necessary to mediate such interaction. Nevertheless, the interaction with PHD1-3 seems to be stronger than
the interaction with PHD2 alone (Table 1).

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 2.
Summary of the deletion analysis of protein-protein
interactions involving the MLL PHD fingers. (A) Using the yeast
two-hybrid system, the interactions of different MLL-PHD finger
constructs containing the first three PHD fingers (fragment
a) or interactions with the full-length Cyp33 protein
were tested. +, ++, or +++ indicate a weaker or stronger positive
interaction, respectively, detected by the induction of
-galactosidase activity. (B) The interactions of different fragments
from the Cyp33 protein with the first three PHD fingers in MLL
construct 1 were analyzed in the same way.
|
|
We have also tested the PHD zinc finger region of the
Drosophila trx protein containing PHD fingers 1 to 3 for
homodimerization
by using the yeast two-hybrid system. The results were
also positive.
However, we could not detect heterodimerization between
the PHD
fingers of MLL and those of trx (Table
1).
To test for homodimerization of the MLL PHD fingers in vitro, the first
three PHD fingers (aa 1394 to 1700) as well as the
full-length PHD
finger cassette (aa 1394 to 2000) were fused to
a GST ORF and were used
in affinity precipitation experiments
(Fig.
3A). The GST-MLL-PHD finger fusion
proteins were expressed
in bacteria and were purified by binding to
glutathione-Sepharose
beads. The full-length PHD zinc finger motif (aa
1394 to 2000)
was synthesized and was
35S labeled in a
coupled transcription-translation system and then
was tested for
binding to the GST-MLL-PHD finger fusion proteins
or to GST alone.
Radiolabeled MLL-PHD1-4 could be affinity purified
by precipitation
with GST-MLL PHD1-3 but not with GST alone. Similar
results were
obtained using the GST fusion protein containing
PHD1-4. These results
indicate that the MLL PHD zinc fingers can
mediate homodimerization in
vitro.

View larger version (53K):
[in this window]
[in a new window]
|
FIG. 3.
Affinity precipitation of 35S-labeled
proteins containing the complete PHD finger cluster of MLL with
different GST fusion proteins: (A) GST fusion proteins containing
either the complete PHD finger cluster of MLL or PHD fingers 1 to 3;
(B) GST-Cyp33 fusion protein. The input lane shows the migration of
proteins from the supernatant from the in vitro
transcription-translation reaction. The GST lane shows the lack of
affinity precipitation with the GST protein alone.
|
|
A nuclear cyclophilin (Cyp33) interacts with the PHD finger domain
of MLL.
To identify proteins that may interact with the MLL PHD
fingers, we performed a yeast two-hybrid screen. We used the first three PHD zinc finger motifs of MLL in the plasmid pGBT9 as the bait. A
HeLa cell cDNA library in the prey vector was used to search for
interacting proteins. The GAL4 DBD-MLL plasmid and the human HeLa cDNA
library in pGAD GH were expressed in the yeast strain Y190. Of
approximately 107 transformants, 60 were isolated as positives from the
initial screening. From these, 40 were considered false positives
because they didn't induce
-galactosidase upon retransformation
into yeast or because they interacted nonspecifically with the GAL4 DBD
alone. The remaining 20 positives were isolated and sequenced, and
their sequences were compared with the sequence databases using the
BLAST program.
Eight of the 20 positive clones contained overlapping cDNAs from
the same gene. The gene encodes a protein of about 30 kDa,
with an RNA
binding domain of the RRM type at its amino terminus.
Separated by a
spacer of 60 amino acids from the RRM amino terminal
domain, there is a
cyclophilin-like domain. A cDNA identical to
the one from this gene was
previously reported (
18,
22) and
was called CyP33 (or
PPIE) (we will call the gene
CYP33 and the
encoded protein
Cyp33). This protein was isolated from the Jurkat
T-cell leukemia cell
line and was found to be present in the nuclear
fraction of Jurkat
cells. The protein binds RNA, with a preference
for A- or T-rich
sequences, and according to in vitro enzymatic
assays it possesses the
prolyl-
cis-
trans-isomerase activity typical
of
cyclophilins, which can be inhibited by cyclosporine (
22).
Hybridization of a cDNA probe encoding sequences from the Cyp33 spacer
region to a Northern blot containing mRNAs from different
human tissues
revealed two main transcripts expressed in a variety
of different
tissues (Fig.
4). Comparison of the
CYP33 cDNA sequence
with nucleotide sequence databases
revealed a strong match with
a cyclophilin gene of the parasitic
flatworm
Schistosoma mansoni (
7) and later on
with cyclophilin genes from other animal species
(M. Anderson, K. Fair,
S. Amero, S. Nelson, P. J. Harte, and M.
O. Diaz, submitted for
publication). The
S. mansoni sequence had
a 5' extension of
its reported ORF that encodes an RRM domain
and spacer, similar to
Cyp33. The protein sequence encoded in
the extended
S. mansoni ORF has 60% identity and a similarity
index of 61.6, as
calculated by Lipman-Pearson Ktuple parameters,
to our human Cyp33
sequence. Such high conservation across evolutionary
boundaries
suggests an important function for all domains of this
protein.

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 4.
Northern blot with mRNA from different human tissues
hybridized to a Cyp33 spacer probe. This probe detects two main
transcripts of 2.5 and 1.8 kb. An actin cDNA probe was hybridized to
the same blot as a loading control shown in the lower panels.
|
|
The third PHD finger of MLL mediates binding of Cyp33.
To
determine the strength and specificity of the interaction between the
MLL zinc fingers and Cyp33 in the yeast two-hybrid system, bait
constructs encoding each of the four MLL PHD fingers were made. We
found that the PHD3 (aa 1555 to 1636) alone was necessary and
sufficient to mediate interaction between Cyp33 and MLL (Fig. 2A). This
motif is separate and distinct from the PHD2 motif that mediates
dimerization of MLL polypeptides.
Cyp33 and the MLL PHD fingers interact in vitro.
We confirmed
the yeast two-hybrid results by standard in vitro binding studies using
purified, bacterially expressed GST-Cyp33 fusion proteins. An HA-MLL
fusion protein containing PHD1-4 was transcribed and translated in
vitro in the presence of [35S]methionine. GST-Cyp33 bound
to glutathione Sepharose beads was able to affinity precipitate
35S-labeled HA-MLL, whereas GST alone did not bring down
HA-MLL in these experiments (Fig. 3B). In addition, GST-Cyp33 did not interact with radiolabeled HA alone. These experiments show a direct
and specific interaction between Cyp33 and the MLL PHD fingers in vitro.
Cyp33 and MLL interact in a mammalian two-hybrid system.
To
determine whether the MLL PHD fingers interact with Cyp33 or mediate
self binding in mammalian cells, we used a modified two-hybrid assay to
examine protein interactions in the nucleus of mammalian cells
(35). The PHD1-3 sequences were cloned into a mammalian
expression vector containing the DNA-binding domain of GAL4. Other
expression vectors were constructed containing the entire Cyp33 protein
or the PHD1-3 sequences fused to the herpesvirus VP16 transactivation domain.
The mammalian two-hybrid assay was performed by transfecting NIH 3T3 or
h293 cells with paired combinations of the appropriate
expression
constructs along with a GAL4-responsive luciferase
reporter gene and a
constitutively active
Renilla luciferase reporter
gene to
normalize for transfection efficiency. Positive interactions
were
determined by evaluating transcriptional activation of the
luciferase
reporter gene. The strength of the interaction was
quantitated by
measuring the luciferase activity of lysates prepared
from transfected
cells (Fig.
5A). Control transfections
show that
coexpression of GAL4-MLL with the VP16 domain alone did not
significantly
induce luciferase activity. Likewise, VP16-MLL or
VP16-Cyp33 in
combination with the GAL4 DNA binding domain alone did
not induce
luciferase activity in mammalian cells. However,
cotransfection
of cells with GAL4-MLL and VP16-Cyp33 resulted in a
large increase
in luciferase activity that was similar to, or greater
than, the
luciferase activity induced by coexpression of GAL4-BRCA1 and
VP16-B202, proteins that are known to interact in mammalian cells
(
35). Coexpression of GAL4-MLL and VP16-MLL resulted in a
small
increase in induced luciferase activity. These results suggest
that the MLL polypeptide and the Cyp33 protein can form stable
interactions in the nucleus of mammalian cells. In addition, the
MLL
PHD1-3 polypeptides also homodimerize, even if with low affinity,
in
mammalian cells.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 5.
(A) Results from the mammalian two-hybrid analysis of
MLL-PHD finger protein interactions. Mouse NIH 3T3 cells were
transiently transfected with the G5LUC reporter construct, the
Renilla luciferase control expression plasmid under the
control of the thymidine kinase gene promoter, and the two indicated
expression vectors. GAL4 or VP16 indicates the DNA binding or
activation domain expression vectors. The other constructs are denoted
by the name of the domain fused to either the GAL4 DNA binding domain
(first column) or the VP16 activation domain (second column). The
BRCA1-BARD1 interaction was used as a positive control
(22). The thick bars represent the average normalized
luciferase activities from three experiments, and the error bars
represent one standard deviation. (B) Immunoprecipitation and Western
blotting of cell lysates from 293 human kidney cells transfected with
an expression plasmid for a FLAG-Cyp33 fusion gene alone or plus
expression plasmids for either a GAL4-MLL fusion protein containing PHD
fingers 1 to 4 or a GAL4-BRCA1 fusion protein; the lysate was
immunoprecipitated with an anti-GAL4 antibody. (C) Immunoprecipitation
and Western blotting of cell lysates from 293 human kidney cells
transfected with only an expression plasmid containing a FLAG-MLL
fusion protein containing the PHD fingers 1 to 4; the
immunoprecipitation was performed with an anti-Cyp33 polyclonal
antibody or with preimmune rabbit serum. In both experiments the
Western blotting was performed with an anti-FLAG antibody. The first
lane in each experiment contains the whole cell lysate without
immunoprecipitation.
|
|
MLL zinc fingers interact with endogenous Cyp33 in vivo.
We
could also confirm by coimmunoprecipitation that the MLL zinc fingers
and Cyp33 protein interact in mammalian cells. Human 293 kidney cells
were transiently transfected with expression plasmids encoding both the
MLL PHD1-3 polypeptide fused to an N-terminal GAL4 DNA binding domain
and the full-length Cyp33 polypeptide with an N-terminal FLAG epitope.
As controls, 293 cells were cotransfected with the GAL4-BRCA1 protein
and FLAG-Cyp33 or with FLAG-Cyp33 alone. When cells were lysed 2 days
after transfection and were immunoprecipitated with antibody to the
GAL4 domain, we found that FLAG Cyp33 coprecipitated with GAL4-MLL
polypeptide (Fig. 5B). This interaction was specific because Cyp33
could not be coprecipitated with GAL4-BRCA1.
To determine whether the MLL zinc fingers can interact with endogenous
Cyp33 protein, 293 cells were transiently transfected
with the MLL
PHD1-3 polypeptide with an N-terminal FLAG epitope.
Cell lysates were
immunoprecipitated with a rabbit antiserum raised
against the Cyp33
protein (
22) or with preimmune rabbit serum.
The
precipitates were fractionated by SDS-PAGE, and the presence
of
FLAG-MLL in the precipitate was determined by Western blot
analysis
with a monoclonal antibody that recognizes the FLAG epitope.
FLAG-MLL coimmunoprecipitated with antiserum specific for Cyp33
but not
with preimmune rabbit serum (Fig.
5C). Therefore, endogenous
Cyp33 can
interact in vivo with the MLL PHD fingers. These experiments
demonstrate that Cyp33 and the MLL PHD fingers interact in mammalian
cells.
The RRM motif of Cyp33 is necessary and sufficient to mediate
protein interaction.
To determine which domains from Cyp33 mediate
the interaction with the MLL PHD fingers, deletion constructs of the
different functional domains of Cyp33 were constructed and were tested
for interaction with the MLL PHD fingers in the yeast two-hybrid assay. Deletions of Cyp33 were fused to the GAL4 activation domain and were
tested for interaction with the GAL4-DNA binding domain-MLL PHD1-3
fusion (Fig. 2B). The strength of the interactions as quantitated by a
liquid
-galactosidase assay for all protein interactions tested in
the yeast two-hybrid system is summarized in Table 1. These results
show that Cyp33 binds the MLL PHD fingers through its RRM domain.
Since the RRM domain is the only region of Cyp33 necessary for
interaction with the MLL PHD fingers and this domain has been
shown to
bind RNA (
22), it is possible that RNA mediates the
protein interaction. To determine if RNA is necessary for the
interaction between Cyp33 and MLL, we added RNase to the
35S-labeled Cyp33 product from our in vivo transcription
translation
reaction (which contains RNA) and tested for its ability to
be
precipitated with GST-PHD1-3. There was no difference in the amount
of radiolabeled Cyp33 that could be precipitated with GST-MLL
bound to
glutathione beads in the presence or absence of RNase
(data not shown).
These results suggest that RNA is not necessary
for and did not
detectably enhance the protein interaction between
Cyp33 and the MLL
PHD
fingers.
MLL and Cyp33 exhibit overlapping patterns of nuclear
localization.
Previously, MLL has been localized to the nucleus in
a speckled punctate pattern, a localization that is mediated by
distinct N-terminal amino acid sequence elements (6, 38).
Cyp33 has also been found in the nuclear fraction of cultured cells
(22). To determine if the nuclear distribution of Cyp33
and MLL are overlapping, the two proteins were transiently expressed
with specific epitope tags in Cos7 or HeLa cells and were localized by
immunostaining. The entire Cyp33 protein tagged with HA or a truncated
version without the cyclophilin domain was coexpressed in cells with
the FLAG-MLL protein. The FLAG-MLL protein included the AT hooks, two
N-terminal elements of the MLL protein necessary and sufficient for its
nuclear localization, PHD1-3, and a FLAG epitope tag.
To characterize the nuclear localization pattern of MLL and Cyp33,
fluorescent confocal microscopy was employed. When FLAG
MLL was
expressed alone in HeLa cells and was visualized by immunostaining,
the
protein distribution showed a distinct pattern of nuclear
speckles as
previously described (
6,
38) (Fig.
6). However,
the HA-Cyp33 protein alone,
with or without the cyclophilin domain,
was distributed uniformly
throughout the nucleus but excluded
from the nucleoli (Fig.
6). In the
Cyp33 and MLL cotransfected
cells, Cyp33 (or its RRM domain) and MLL
always showed an overlapping
pattern of nuclear distribution (Fig.
6).
The two proteins colocalized
to distinct nuclear speckles in about 30%
of the double-positive
cells. The remaining 70% of double-stained
cells showed a nuclear
speckled staining against a more diffuse pattern
uniformly distributed
throughout the nucleus. The distribution of the
proteins to the
nuclear speckles always depended on the presence of
expressed
MLL, since 100% of the cells that expressed Cyp33 alone
showed
a diffuse pattern of protein distribution throughout the
nucleus.

View larger version (106K):
[in this window]
[in a new window]
|
FIG. 6.
HeLa cells transfected with an expression construct
encoding a FLAG-MLL fusion protein containing the AT hooks, nuclear
localization domains, and the first three PHD fingers of MLL and an
expression construct encoding a HA-Cyp33 fusion protein. The fixed
cells were stained with an anti-FLAG antibody coupled to Texas red (red
fluorescence) and with an anti-HA antibody coupled to fluorescein
isothiocyanate (FITC; green fluorescence). The cells were analyzed with
a fluorescence confocal microscope, and the images show the fluorescent
image from the anti-HA-FITC antibody (panels 3, 6, and 9), from the
anti-FLAG-Texas red antibody (panels 1, 4, and 7), or the overlap of
both fluorescent images. Three cells are shown, one expressing only the
FLAG-MLL protein (panels 1 to 3), one expressing both proteins (panels
4 to 6), and one expressing only the HA-Cyp33 protein (panels 7 to 9).
It can be seen that the HA-Cyp33 protein is diffusely distributed in
the nucleus when expressed alone but localizes to the MLL-containing
speckles when expressed with FLAG-MLL.
|
|
Effects of Cyp33 overexpression on the regulation of MLL target
genes.
We wanted to study the possible effects of Cyp33
overexpression on the transcriptional regulation of target genes of
MLL. For this purpose we set up the following experiment. We
transfected a Cyp33-expressing plasmid into three leukemia cell lines:
K562, ML-1, and THP1. K562 is derived from a patient with chronic
myelogenous leukemia in blast crisis (21), which has two
normal MLL alleles (13). ML-1 is derived from a
patient with acute myeloblastic leukemia; these cells have two chimeric
MLL-AF6 fusion genes without PHD fingers and with no normal
MLL allele (31). THP1 is derived from a patient
with monocytic acute myeloblastic leukemia, and it has an
MLL-AF9 fusion gene and a normal MLL allele
(23). The three cell lines express HOXC6,
HOXC8, and HOXC9 mRNAs at levels detectable by RT-PCR.
These three HOX genes are regulated by MLL in cells from
MLL mutant mice (14). The overexpression of
Cyp33 induced a marked down-regulation of HOXC8 and
HOXC9 mRNA and induced an up-regulation of HOXC6
in the K562 cell line but produced no change in the expression of these
genes in the ML-1 and THP1 cell lines (Fig.
7A). Overexpression either of the empty vector or of vectors expressing truncated forms of Cyp33 lacking either
the cyclophilin domain or the RRM domain plus the spacer produced no
significant effect in either of the three cell lines (Fig. 7A).

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 7.
(A) RT-PCR products from mRNA of K562, ML-1, and THP1
human leukemia cells transfected with different plasmid constructs. V,
the plasmid vector without an insert; Cyp33, an expression plasmid
encoding Cyp33; RRM, an expression plasmid encoding a truncated version
of Cyp33 that lacks the cyclophilin domain; Cyp, a truncated construct
that lacks the RRM domain and the spacer but retains the cyclophilin
domain. Different pairs of primers, specific for the genes HOXC8,
HOXC9, HOXC6, and glyceraldehyde phosphate dehydrogenase
(GAPDH), were used. In addition, a forward primer within the
HA coding sequence and reverse primers within sequences encoding either
the RRM domain or the cyclophilin domain of Cyp33 were used to detect
the expression of mRNA encoding the fusion proteins by PCR. (B) RT-PCR
products from the mRNA of K562 human leukemia cells transfected with
the same plasmid constructs as in panel A and cultured with or without
cyclosporine. The same PCR primers as in panel A were used for
RT-PCR.
|
|
In order to determine if the effect of Cyp33 overexpression was
dependent on the PPIase activity of Cyp33, we repeated the
experiment
in the presence of cyclosporine, a cyclophilin-specific
PPIase
inhibitor. Cyclosporine completely suppressed both the
down-regulation
of
HOXC8 and the up-regulation of
HOXC6
expression
in the K562 cell line transfected with the Cyp33 expression
construct.
Nevertheless, cyclosporine had no effect on the expression
of
HOXC8 and
HOXC6 in the controls transfected
with empty vector
or with the truncated version of Cyp33 without the
cyclophilin
domain (Fig.
7B) or on the ML-1 cells transfected with
the same
constructs (data not
shown).
 |
DISCUSSION |
The PHD fingers mediate protein-protein interactions.
The
presence of PHD fingers in many chromatin-associated proteins and their
evolutionary conservation within different protein families suggested
that they perform fundamental functions in these proteins.
Nevertheless, it was not known if these domains interacted with nucleic
acids, like many Krox-type Zn fingers, or with proteins. The results
presented in this paper show that the PHD fingers could mediate
protein-protein interactions.
The MLL and trx PHD fingers homodimerize.
The first three PHD
fingers of both MLL and trx homodimerize in vitro in the yeast
two-hybrid assay and more weakly in the mammalian cell two-hybrid
assay. Even if the isolated PHD finger dimerization function is
relatively weak, it may mediate dimerization of the intact protein in
vivo, acting cooperatively with other dimerization domains like the SET
domain (27). Dimerization of MLL and trx may have a role
in the assembly of maintenance complexes after the components of such
complexes are dispersed to the two daughter DNA strands during
replication. Therefore, trx and MLL dimerization may be an important
component of the mechanism of propagation of maintenance for active loci.
In all MLL fusion proteins associated with leukemia this dimerization
domain is deleted from the functional product, as is
the other known
dimerization domain, the SET domain. Nevertheless,
in some fusion
proteins the partner protein contributes a dimerization
domain
(
26,
32). It is possible that dimerization of the central
region of MLL and trx, mediated by PHD2, allows molecules docked
on the
other PHD fingers, such as Cyp33, to target the partner
MLL molecule in
a way similar to that in which reciprocal phosphorylation
of certain
transmembrane receptors occurs after
dimerization.
MLL binds Cyp33 through its third PHD finger.
The interaction
of MLL and Cyp33 is conserved in Drosophila, where the third
PHD finger of trx interacts with the Drosophila homologue of
Cyp33 (Anderson et al., submitted). Our dissection of the interaction
domains shows that the third PHD finger of MLL is necessary and
sufficient for Cyp33 binding and that the first and second PHD fingers
do not interact with Cyp33. The MLL PHD2 has, as a distinctive feature,
a cluster of acidic amino acid residues in the first spacer and several
acidic residues in the third spacer. These features are conserved with
the third PHD fingers of the other sequenced proteins of the trx/MLL
family (Fig. 1).
The interacting domain in Cyp33 was identified as the RRM domain. This
interaction is specific to Cyp33, since the RRM domains
of another RNA
binding protein, Non-O (
37), do not bind to the
MLL PHD
fingers. Even if RRM domains have been found to interact
specifically
with RNA, there are precedents for RRM domain proteins
that interact
without the intermediation of RNA, as in the case
of the interaction
between the Sxl and Sin
Drosophila proteins
(
9). Sxl has two RRM domains while Sin, like MLL PHD2 (see
Fig.
1), has two clusters of acidic residues in its sequence.
It is
possible that basic residues on the RRM domain interact
electrostatically with the acidic residues in Sin and in MLL PHD3
and,
alternatively, with the phosphate groups of
RNA.
On the other hand, it has been reported that dimerization of Sxl
through its RRM domains is mediated by RNA (
28). Cyp33
has
been reported to bind poly(A) or poly(U) polyribonucleotides
(
22) but our results suggest that the interaction between
MLL
and Cyp33 does not require RNA. Alternatively, it is possible
that
RNA competes with MLL for binding to the RRM domain of Cyp33.
As
proposed below, competition with nascent RNA transcripts could
provide
a mechanism for the recognition of transcriptionally active
loci by the
MLL
complex.
Colocalization of MLL and Cyp33.
MLL has been shown to
localize in nuclear subdomains described as irregular-size speckles
identified by some authors as part of the nuclear matrix (6,
38). When Cyp33 is coexpressed in the same cells, it colocalizes
with the MLL fragment. Nevertheless, for Cyp33 the discrete
localization is dependent on simultaneous overexpression of MLL. In the
absence of overexpressed MLL, Cyp33 localizes diffusely within the
nucleus. This suggests that the localization of Cyp33 to specific
nuclear subdomains is mediated by its binding to MLL. The concentration
of endogenous MLL is too low to target detectable amounts of Cyp33 to
the same domains. The nuclear sublocalization of Cyp33 does not seem to
depend on its PPIase function, since a truncated form of the protein
without the cyclophilin domain shows the same localization as the whole protein.
Overexpression of Cyp33 modulates the gene regulatory function of
MLL.
The HOC8 and HOXC9 mRNA levels are
down-regulated in Mll null fibroblasts. The HOXC6
mRNA is also down-regulated but to a lesser extent
(14). Overexpression of Cyp33 from an expression vector
results in down-regulation of the HOXC8 and HOXC9
mRNAs in the leukemia cell line K562, which has two normal
MLL alleles. This down-regulation is inhibited by
cyclosporine and is not observed in the leukemia cell lines ML-1 and
THP1, which have mutant MLL alleles without PHD fingers and
have either no normal MLL allele or one such allele,
respectively. In addition, overexpression of truncated proteins that
lack either the RRM domain and the spacer or the cyclophilin domain has
no effect on the expression of these HOX genes. This is
consistent with the observed down-regulation being mediated by the
binding of Cyp33 to the PHD fingers of MLL and the targeting of the
PPIase activity of its cyclophilin domain either to other domains of
MLL or to associated proteins. The opposite effect, up-regulation, was
observed for the HOXC6 mRNA, and this up-regulation was also
eliminated by cyclosporine. It is possible that one of these two
effects is indirect and could be explained if some of the HOX proteins
act as repressors of the other HOX gene, i.e., if HOXC8
and/or HOXC9 repress the HOXC6 gene.
Since Cyp33 is present in the cell at a higher concentration than MLL,
one can ask why a further increase in the concentration
of Cyp33 would
affect MLL function. The answer could be that Cyp33
can bind AU-rich
RNA transcripts within the cell (
22). Only
when
overexpressed will it titer all the RNA transcripts and then
be able to
bind to
MLL.
The
HOXC9 gene is an ortholog of the
Drosophila
gene
AbdB. Down-regulation of
AbdB expression
after overexpression of the
DmCyp33 protein in
Drosophila
SL1 cells has been reported (Anderson
et al., submitted).
abdB is a
Hox gene regulated by
Drosophila trithorax and polycomb group proteins. This
observation suggests
that modulation of
Hox gene expression
through the interaction
of Cyp33 and trx and MLL proteins is a
fundamental feature of
epigenetic regulation across
evolution.
The observation that the expression of
HOXC8 is not altered
by Cyp33 overexpression in ML-1 and THP1 cells, which have chimeric
MLL genes, is consistent with the hypothesis previously put
forward
by Slany et al. (
30) that the chimeric MLL
proteins have constitutive
transactivation activity. Nevertheless, our
results suggest that
this constitutive activity results not only from
the possible
contribution of an activation domain by the fusion partner
(AF6
and AF9 in these cases) but also from the lack of negative
regulation
by factors normally bound to the PHD fingers, such as
Cyp33.
There are precedents for the participation of cyclophilins in the
modulation of gene regulation by transcription factors.
Cyclophilin A
has been reported to interact with the transcription
factor YY1 and
modulate its repressing or transactivating activity
in a cyclosporine
sensitive way (
36). It is interesting that
YY1 shares
sequence similarity and similar DNA binding sites with
Pho, a
Drosophila Pc-G protein (
5). Another
cyclophilin, Cyp40,
binds to the transcription factor c-myb and
inhibits its DNA binding
activity and transactivation activity in a
cyclosporine dependent
way (
19). Cyp40 does not inhibit
DNA binding of v-Myb, which
has mutations in the Cyp40 binding domain.
Cyp40 is also part
of a chaperone complex associated with nuclear
steroid receptors
and is needed for its normal ligand interactions and
consequent
transactivation function (
10,
24). A recent
report (
2)
suggests that cyclophilin A and PIN, two prolyl
isomerases, have
a function in the regulation of repression by
sin3-histone deacetylase
complexes.
We do not know which domain of MLL, if any, is targeted by the
cyclophilin domain of Cyp33, but the effect of Cyp33 on MLL
or on its
associated proteins may play a role in the initiation
of maintenance by
promoting repression by MLL complexes assembled
on inactive loci. In
one possible model, during the initiation
of maintenance at inactive
loci, Cyp33 would be bound to MLL,
promoting repression and allowing
the assembly of Pc-G complexes
on such loci. At transcriptionally
active loci, Cyp33 would be
displaced from its association with MLL by
AU-rich nascent RNA
transcripts, allowing MLL to function as an
activator that prevents
the assembly of Pc-G repression complexes (Fig.
8). Consistent
with this model, it has
been reported that in
Drosophila, noncoding
RNA transcripts
arise from most BX-C enhancer sequences, overlapping
PREs and TREs, the
sites of binding of trx-G and Pc-G protein
complexes (
20,
29); these transcripts have many A and U nucleotide
stretches.
Noncoding transcripts have been described also from
at least one of the
mammalian
HOX gene clusters (
15,
25).
A
prediction of this model is that the loss of the PHD fingers
after
splitting of the
MLL gene by an 11q23 translocation would
eliminate Cyp33 binding, turning MLL into a constitutive activator.
This could result in alterations of MLL target gene expression,
thus
contributing to leukemia.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 8.
Model of the modulation of MLL effects on target genes
by Cyp33. After binding the PHD fingers, Cyp33 may target activating or
repressing domains of MLL to prevent binding of activators or to
promote binding of repressors, thus enhancing the repressing functions
of MLL. At transcriptionally active loci during early embryonic
development, Cyp33 is sequestered onto the nascent transcripts and MLL
is released from its regulation, thus becoming an activator.
|
|
 |
ACKNOWLEDGMENTS |
We are grateful to Richard Baer for providing the vector
constructs for the mammalian two-hybrid system and to Yih-Sheng Yang for yeast two-hybrid control plasmids GBT-NonO and GAD-NonO. We thank
Peter Harte and Stephanie L. Nelson for trithorax yeast two-hybrid
constructs. We also thank Nancy Zeleznik-Le for GST-MLL fusion protein
constructs and discussion of results and K. FitzGerald and U. Osmers
for discussion and help in editing the manuscript.
This work was supported by U.S. Public Health Service Grant ROI CA38725
(to M.O.D.) and by Deutsche Forschungsgemeinschaft (SFB 388/B3) and the
Fonds der Chemischen Industrie (to M.T.).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Loyola
University Medical Center, Cancer Center Bldg. 112, Rm. 333, 2160 South
First Ave., Maywood, IL 60153. Phone: (708) 327-3172. Fax: (708)
327-3342. E-mail: mdiaz2{at}lumc.edu.
 |
REFERENCES |
| 1.
|
Aasland, R.,
T. J. Gibson, and A. F. Stewart.
1995.
The PHD finger: implications for chromatin-mediated transcriptional regulation.
Trends Biochem. Sci.
20:56-59[CrossRef][Medline].
|
| 2.
|
Arevalo-Rodriguez, M.,
M. E. Cardenas,
X. Wu,
S. D. Hanes, and J. Heitman.
2000.
Cyclophilin A and Essl interact with and regulate silencing by the Sin3-Rpd3 histone deacetylase.
EMBO J.
19:3739-3749[CrossRef][Medline].
|
| 3.
|
Birney, E.,
S. Kumar, and A. R. Krainer.
1993.
Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors.
Nucleic Acids Res.
21:5803-5816[Abstract/Free Full Text].
|
| 4.
|
Breen, T. R., and P. J. Harte.
1991.
Molecular characterization of the trithorax gene, a positive regulator of homeotic gene expression in Drosophila.
Mech. Dev.
35:113-127[CrossRef][Medline].
|
| 5.
|
Brown, J. L.,
D. Mucci,
M. Whiteley,
M. L. Dirksen, and J. A. Kassis.
1998.
The Drosophila polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1.
Mol. Cell
1:1057-1064[CrossRef][Medline].
|
| 6.
|
Butler, L. H.,
R. Slany,
X. Cui,
M. L. Cleary, and D. Y. Mason.
1997.
The HRX Proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
Blood
89:3361-3370[Abstract/Free Full Text].
|
| 7.
|
Davis, R. E.,
C. Hardwick,
P. Tavernier,
S. Hodgson, and H. Singh.
1995.
RNA transplicing in flatworms.
J. Biol. Chem.
270:21813-21819[Abstract/Free Full Text].
|
| 8.
|
Djabali, M.,
L. Selleri,
P. Parry,
M. Bower,
B. D. Young, and G. A. Evans.
1992.
A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukemias.
Nat. Genet.
2:113-118[CrossRef][Medline].
|
| 9.
|
Dong, Z., and L. R. Bell.
1999.
SIN, a novel Drosophila protein that associates with the RNA binding protein sex-lethal.
Gene
237:421-428[CrossRef][Medline].
|
| 10.
|
Duina, A. A.,
H.-C. J. Chang,
J. A. Marsh,
S. Lindquist, and R. F. Gaber.
1996.
A cyclophilin function in Hsp90-dependent signal transduction.
Science
274:1713-1715[Abstract/Free Full Text].
|
| 11.
|
FitzGerald, K. T., and M. O. Diaz.
1999.
MLL2: a new mammalian member of the trx/MLL family of genes.
Genomics
59:187-192[CrossRef][Medline].
|
| 12.
|
Grieco, F.,
J. M. Hay, and R. Hull.
1992.
An improved procedure for the purification of protein fused with glutathione S-transferase.
BioTechniques
13:856-857[Medline].
|
| 13.
|
Gu, Y.,
T. Nakamura,
H. Alder,
R. Prasad,
O. Canaani,
G. Cimino,
C. Croce, and E. Canaani.
1992.
The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to drosophila trithorax, to the AF-4 gene.
Cell
71:701-708[CrossRef][Medline].
|
| 14.
|
Hanson, R. D.,
J. L. Hess,
B. D. Yu,
P. Ernst,
M. van Lohuizen,
A. Berns,
N. M. van der Lugt,
C. S. Shashikant,
F. H. Ruddle,
M. Seto, and S. J. Korsmeyer.
1999.
Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development.
Proc. Natl. Acad. Sci. USA
96:14372-14377[Abstract/Free Full Text].
|
| 15.
|
Hsieh-Li, H. M.,
D. P. Witte,
M. Weinstein,
W. Branford,
H. Li,
K. Small, and S. S. Potter.
1995.
Hoxa11 structure, extensive antisense transcription, and function in male and female fertility.
Development
121:1373-1385[Abstract].
|
| 16.
|
Jeanmougin, F.,
J.-M. Wurtz,
B. Le Douarin,
P. Chambon, and R. Losson.
1997.
The bromodomain revisited.
Trends Biochem. Sci.
22:151-153[CrossRef][Medline].
|
| 17.
|
Kennison, J. A.
1995.
The polycomb and trithorax group proteins of Drosophila: trans-regulators of homeotic gene function.
Annu. Rev. Genet.
29:289-303[CrossRef][Medline].
|
| 18.
|
Kim, J. O.,
M. M. Nau,
K. A. Allikian,
T. P. Makela,
K. Alitalo,
B. E. Johnson, and M. J. Kelley.
1998.
Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines.
Oncogene
17:1019-1026[CrossRef][Medline].
|
| 19.
|
Leverson, J. D., and S. A. Ness.
1998.
Point mutations in v-Myb disrupt a cyclophilin-catalyzed negative regulatory mechanism.
Mol. Cell
1:203-211[CrossRef][Medline].
|
| 20.
|
Lipshitz, H. D.,
D. Peattie, and D. S. Hogness.
1987.
Novel transcripts from the Ultrabithorax domain of the bithorax complex.
Genes Dev.
1:307-322[Abstract/Free Full Text].
|
| 21.
|
Lozzio, C. B., and B. B. Lozzio.
1975.
Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome.
Blood
45:321-334[Abstract/Free Full Text].
|
| 22.
|
Mi, H.,
E. Zimmerman,
A. Jäschke, and M. Tropschug.
1996.
A nuclear RNA binding cyclophilin in human T cells.
FEBS Lett.
398:201-205[CrossRef][Medline].
|
| 23.
|
Odero, M. D.,
N. J. Zeleznik-Le,
V. Chinwalla, and J. D. Rowley.
2000.
Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP-1 with an MLL-AF9 translocation.
Genes Chromosomes Cancer
29:333-338[CrossRef][Medline].
|
| 24.
|
Owens-Grillo, J. K.,
K. Hoffmann,
K. A. Hutchison,
A. W. Yem,
M. R. Deibel,
R. E. Handschumacher, and W. B. Pratt.
1995.
The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor.
J. Biol. Chem.
270:20479-20484[Abstract/Free Full Text].
|
| 25.
|
Potter, S. S., and W. W. Branford.
1998.
Evolutionary conservation and tissue-specific processing of Hoxa11 antisense transcripts.
Mammalian Genome
9:799-806.
|
| 26.
|
Prasad, R.,
D. Leshkowitz,
Y. Gu,
H. Alder,
T. Nakamura,
H. K. Saito,
R. Berger,
C. M. Croce, and E. Canaani.
1994.
Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukemia.
Proc. Natl. Acad. Sci. USA
91:8107-8111[Abstract/Free Full Text].
|
| 27.
|
Rozovskaia, T.,
O. Rozenblatt-Rosen,
Y. Sedkov,
D. Burakov,
T. Yano,
T. Nakamura,
S. Petruk,
L. Ben-Simchon,
C. M. Croce,
A. Mazo, and E. Canaani.
2000.
Self-association of the SET domains of human ALL-1 and of Drosophila TRITHORAX and ASH1 proteins.
Oncogene
19:351-357[CrossRef][Medline].
|
| 28.
|
Sakashita, E., and H. Sakamoto.
1996.
Protein-RNA and protein-protein interactions of the Drosophila sex-lethal mediated by its RNA-binding domains.
J. Biochem.
120:1028-1033[Abstract/Free Full Text].
|
| 29.
|
Sanchez-Herrero, E., and M. Akam.
1989.
Spatially ordered transcription of regulatory DNA in the bithorax complex of Drosophila.
Development
107:321-329[Abstract].
|
| 30.
|
Slany, R. K.,
C. Lavau, and M. L. Cleary.
1998.
The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.
Mol. Cell. Biol.
18:122-129[Abstract/Free Full Text].
|
| 31.
|
Strout, M. O.,
K. Mrozek,
K. Heinonen,
S. N. J. Sait,
T. B. Shows, and P. D. Aplan.
1996.
ML-1 cell line lacks a germline MLL locus.
Genes Chromosomes Cancer
16:204-210[CrossRef][Medline].
|
| 32.
|
Taki, T.,
Y. Hayashi,
M. Taniwaki,
M. Seto,
R. Ueda,
R. Hanada,
K. Suzukawa,
J. Yokota, and K. Morishita.
1996.
Fusion of the MLL gene with two different genes, AF-6 and AF-5 alpha, by a complex translocation involving chromosomes 5, 6, 8 and 11 in infant leukemia.
Oncogene
13:2121-2130[Medline].
|
| 33.
|
Thirman, M. J.,
H. J. Gill,
R. C. Burnett,
D. Mbangkollo,
N. R. McCabe,
H. Kobayashi,
S. Ziemin-van der Poel,
Y. Kaneko,
R. Morgan,
A. A. Sandberg,
R. S. K. Chaganti,
R. A. Larson,
M. L. Bean,
M. O. Diaz, and J. D. Rowley.
1993.
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.
N. Engl. J. Med.
329:909-917[Abstract/Free Full Text].
|
| 34.
|
Tkachuk, D. C.,
S. Kohler, and M. L. Cleary.
1992.
Involvement of a homolog of Drosophila trithorax by 11q23 chomosomal translocations in acute leukemias.
Cell
71:691-697[CrossRef][Medline].
|
| 35.
|
Wu, L. C.,
Z. W. Wang,
J. T. Tsan,
M. A. Spillman,
A. Phung,
X. L. Xu,
M. C. Yang,
L. Y. Hwang,
A. M. Bowcock, and R. Baer.
1996.
Identification of a RING protein that can interact in vivo with the BRCA1 gene product.
Nat. Genet.
14:430-440[CrossRef][Medline].
|
| 36.
|
Yang, W.-M.,
C. J. Inouye, and E. Seto.
1995.
Cyclophilin A and FKBP12 interact with YY1 and alter its transcriptional activity.
J. Biol. Chem.
270:15187-15193[Abstract/Free Full Text].
|
| 37.
|
Yang, Y. S.,
J. H. Hanke,
L. Carayannopoulos,
C. M. Craft,
J. D. Capra, and P. W. Tucker.
1993.
NonO, a non-POU-domain-containing, octamer-binding protein, is the mammalian homolog of Drosophila nonAdiss. Mol.
Cell. Biol.
13:5593-5603.
|
| 38.
|
Yano, T.,
T. Nakamura,
J. Blechman,
C. Sorio,
C. V. Dang,
B. Geiger, and E. Canaani.
1997.
Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N-terminus of the protein.
Proc. Natl. Acad. Sci. USA
94:7286-7291[Abstract/Free Full Text].
|
| 39.
|
Zeleznik-Le, N. J.,
A. M. Harden, and J. D. Rowley.
1994.
11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene.
Proc. Natl. Acad. Sci. USA
91:10610-10614[Abstract/Free Full Text].
|
| 40.
|
Ziemin-van der Poel, S.,
N. McCabe,
H. J. Gill,
R. Espinosa III,
Y. Patel,
A. Harden,
P. Rubinelli,
S. D. Smith,
M. M. Le Beau,
J. D. Rowley, and M. O. Diaz.
1991.
Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.
Proc. Natl. Acad. Sci. USA
88:10735-10739[Abstract/Free Full Text].
|
Molecular and Cellular Biology, May 2001, p. 3589-3597, Vol. 21, No. 10
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.10.3589-3597.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Muntean, A. G., Giannola, D., Udager, A. M., Hess, J. L.
(2008). The PHD fingers of MLL block MLL fusion protein-mediated transformation. Blood
112: 4690-4693
[Abstract]
[Full Text]
-
Chen, J., Santillan, D. A., Koonce, M., Wei, W., Luo, R., Thirman, M. J., Zeleznik-Le, N. J., Diaz, M. O.
(2008). Loss of MLL PHD Finger 3 Is Necessary for MLL-ENL-Induced Hematopoietic Stem Cell Immortalization. Cancer Res.
68: 6199-6207
[Abstract]
[Full Text]
-
Lindsey, S., Huang, W., Wang, H., Horvath, E., Zhu, C., Eklund, E. A.
(2007). Activation of SHP2 Protein-tyrosine Phosphatase Increases HoxA10-induced Repression of the Genes Encoding gp91PHOX and p67PHOX. J. Biol. Chem.
282: 2237-2249
[Abstract]
[Full Text]
-
Dubourg, B., Kamphausen, T., Weiwad, M., Jahreis, G., Feunteun, J., Fischer, G., Modjtahedi, N.
(2004). The Human Nuclear SRcyp Is a Cell Cycle-regulated Cyclophilin. J. Biol. Chem.
279: 22322-22330
[Abstract]
[Full Text]
-
Daser, A., Rabbitts, T. H.
(2004). Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev.
18: 965-974
[Full Text]
-
Voas, M. G., Rebay, I.
(2003). The Novel Plant Homeodomain Protein Rhinoceros Antagonizes Ras Signaling in the Drosophila Eye. Genetics
165: 1993-2006
[Abstract]
[Full Text]
-
Xia, Z.-B., Anderson, M., Diaz, M. O., Zeleznik-Le, N. J.
(2003). MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc. Natl. Acad. Sci. USA
100: 8342-8347
[Abstract]
[Full Text]
-
Tie, F., Prasad-Sinha, J., Birve, A., Rasmuson-Lestander, A., Harte, P. J.
(2003). A 1-Megadalton ESC/E(Z) Complex from Drosophila That Contains Polycomblike and RPD3. Mol. Cell. Biol.
23: 3352-3362
[Abstract]
[Full Text]
-
Hsieh, J. J.-D., Ernst, P., Erdjument-Bromage, H., Tempst, P., Korsmeyer, S. J.
(2003). Proteolytic Cleavage of MLL Generates a Complex of N- and C-Terminal Fragments That Confers Protein Stability and Subnuclear Localization. Mol. Cell. Biol.
23: 186-194
[Abstract]
[Full Text]
-
Yokoyama, A., Kitabayashi, I., Ayton, P. M., Cleary, M. L., Ohki, M.
(2002). Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties. Blood
100: 3710-3718
[Abstract]
[Full Text]
-
Lee, J.-H., Skalnik, D. G.
(2002). CpG-binding Protein Is a Nuclear Matrix- and Euchromatin-associated Protein Localized to Nuclear Speckles Containing Human Trithorax. IDENTIFICATION OF NUCLEAR MATRIX TARGETING SIGNALS. J. Biol. Chem.
277: 42259-42267
[Abstract]
[Full Text]
-
Cavarec, L., Kamphausen, T., Dubourg, B., Callebaut, I., Lemeunier, F., Metivier, D., Feunteun, J., Fischer, G., Modjtahedi, N.
(2002). Identification and Characterization of Moca-cyp. A DROSOPHILA MELANOGASTER NUCLEAR CYCLOPHILIN. J. Biol. Chem.
277: 41171-41182
[Abstract]
[Full Text]
-
O'Connell, S., Wang, L., Robert, S., Jones, C. A., Saint, R., Jones, R. S.
(2001). Polycomblike PHD Fingers Mediate Conserved Interaction with Enhancer of Zeste Protein. J. Biol. Chem.
276: 43065-43073
[Abstract]
[Full Text]
-
Khodarev, N. N., Park, J. O., Yu, J., Gupta, N., Nodzenski, E., Roizman, B., Weichselbaum, R. R.
(2001). Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts. Proc. Natl. Acad. Sci. USA
98: 12665-12670
[Abstract]
[Full Text]